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Background:  Atherosclerotic change that occurs within stents is referred to as neoatherosclerosis and following bare metal stents (BMS) 
implantation is usually rare occuring beyond 5 years. The incidence of neoatherosclerosis following drug-eluting stents (DES) implantation however, 
has not been reported. The objective of this study was to examine human coronary BMS and DES from autopsy cases with implant durations >30 
days for the presence of neoatherosclerosis.
Methods:  All available cases from the CVPath stent registry (n=299 autopsies), which includes a total of 406 lesions (197 BMS, 209 DES 
[103 sirolimus-eluting stents (SES), and 106 paclitaxel-eluting stents (PES)]) with implant durations exceeding 30 days were examined. 
Neoatherosclerosis was recognized as clusters of lipid-laden foamy macrophages within the neointima with or without necrotic core formation.
Results:  The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS (16%) lesions (p<0.001). The median stent 
duration with neoatherosclerosis was shorter in DES than BMS (DES; 420 [361-683], BMS; 2160 [1800-2880] days, p<0.001). Unstable lesions 
characterized as thin-cap fibroatheromas or plaque rupture were more frequent in BMS (n=7, 4%) than DES (n=3, 1%) (p=0.17), with relatively 
shorter implant durations for DES (1.5±0.4 years) compared to BMS (6.1±1.5 years). Independent determinants of neoatherosclerosis identified by 
multiple logistic regression included younger age (p<0.001), longer implant durations (p<0.001), SES usage (p<0.001), PES usage (p=0.001), and 
underlying unstable plaques (p=0.004).
Conclusions:  Neoatherosclerosis is a frequent finding in DES and occurs earlier than in BMS. Unstable features of neoatherosclerosis are 
identified for both BMS and DES with short implant durations for the latter. The development of neoatherosclerosis represents yet another 
contributing factor to late thrombotic events associated with DES and BMS.
